Director - T cell strategy, Novel Platforms

Role: Lead Lilly’s biology strategy for novel immunology platform projects, focusing on autoimmune disease therapeutics. Responsibilities: develop and validate next-generation platform technologies across multiple targets, oversee biological validation including in vivo studies, evaluate external programs and partnerships, and align cross-functional teams on platform design and application. Requirements: PhD in immunology, pharmacology, cell biology, or related field; 5-10 years’ experience with autoimmune disease research, platform development, and in vivo validation. Preferred: expertise in autoimmune diseases, experience building and implementing new therapeutic platforms, demonstrated leadership in a matrixed research setting, and strong scientific judgment for high-uncertainty decision-making. HighValue: autoimmune and immunology disease biology, biologics or novel modalities, early to late-stage validation, cross-functional collaboration, external technology assessment, strategic decision-making, and leadership in a scientific R&D environment.